| 000 | 01082 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250512204220.0 | ||
| 264 | 0 | _c19810820 | |
| 008 | 198108s 0 0 eng d | ||
| 022 | _a0034-5164 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBasinger, M A | |
| 245 | 0 | 0 |
_aStructural requirements for chelate antidotal efficacy in acute antimony(III) intoxication. _h[electronic resource] |
| 260 |
_bResearch communications in chemical pathology and pharmacology _cMay 1981 |
||
| 300 |
_a355-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntidotes _xtherapeutic use |
| 650 | 0 | 4 |
_aAntimony _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aChelating Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDimercaprol _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPenicillamine _xtherapeutic use |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aSuccimer _xtherapeutic use |
| 700 | 1 | _aJones, M M | |
| 773 | 0 |
_tResearch communications in chemical pathology and pharmacology _gvol. 32 _gno. 2 _gp. 355-63 |
|
| 999 |
_c6264487 _d6264487 |
||